BioNTech (NASDAQ:BNTX – Get Free Report) will be announcing its earnings results before the market opens on Monday, November 4th. Analysts expect the company to announce earnings of ($1.06) per share ...
Increasing lung cancer rates among non-smokers in India are linked to air pollution, secondhand smoke, and genetic factors. A ...
Like other vaccines, BNT116 teaches the immune system to recognize a specific thing and realize that it’s bad You can save ...
At the end of August 2024, mRNA vaccine leader BioNTech (producer of the “Pfizer vaccine”) announced that it started global clinical trials in 7 countries and 34 research sites for a mRNA-based lung ...
The investigational lung cancer mRNA immunotherapy for non-small cell lung cancer (NSCLC), known as BNT116, uses messenger RNA (mRNA) to present common tumor markers from NSCLC to the patient’s immune ...